ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 122 filers reported holding ANIKA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,150,068 | +27.1% | 140,205 | +2.2% | 0.31% | +20.3% |
| Q3 2022 | $3,264,000 | +4.7% | 137,126 | -1.8% | 0.26% | +8.5% |
| Q2 2022 | $3,117,000 | -9.0% | 139,661 | +2.4% | 0.24% | +8.8% |
| Q1 2022 | $3,425,000 | -25.5% | 136,381 | +6.4% | 0.22% | -13.5% |
| Q4 2021 | $4,595,000 | -15.8% | 128,231 | +0.0% | 0.25% | -13.7% |
| Q3 2021 | $5,457,000 | +3.7% | 128,219 | +5.5% | 0.29% | +5.8% |
| Q2 2021 | $5,261,000 | +5.7% | 121,524 | -0.4% | 0.28% | +0.4% |
| Q1 2021 | $4,976,000 | +44.7% | 121,998 | +60.5% | 0.27% | +51.4% |
| Q4 2020 | $3,440,000 | +80.7% | 75,995 | +41.3% | 0.18% | +49.6% |
| Q3 2020 | $1,904,000 | -88.8% | 53,799 | -87.0% | 0.12% | -85.4% |
| Q1 2015 | $16,992,000 | +1.4% | 412,720 | +0.3% | 0.83% | -3.5% |
| Q4 2014 | $16,762,000 | +2552.2% | 411,440 | +2286.5% | 0.86% | +2503.0% |
| Q3 2014 | $632,000 | – | 17,240 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |